International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ... The lancet oncology 15 (12), e538-e548, 2014 | 5240 | 2014 |
International staging system for multiple myeloma PR Greipp, JS Miguel, BGM Durie, JJ Crowley, B Barlogie, J Bladé, ... Journal of clinical oncology 23 (15), 3412-3420, 2005 | 3807 | 2005 |
Review of 1027 patients with newly diagnosed multiple myeloma RA Kyle, MA Gertz, TE Witzig, JA Lust, MQ Lacy, A Dispenzieri, ... Mayo clinic proceedings 78 (1), 21-33, 2003 | 3317 | 2003 |
Improved survival in multiple myeloma and the impact of novel therapies SK Kumar, SV Rajkumar, A Dispenzieri, MQ Lacy, SR Hayman, FK Buadi, ... Blood, The Journal of the American Society of Hematology 111 (5), 2516-2520, 2008 | 2832 | 2008 |
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ... The lancet oncology 17 (8), e328-e346, 2016 | 2623 | 2016 |
A long-term study of prognosis in monoclonal gammopathy of undetermined significance RA Kyle, TM Therneau, SV Rajkumar, JR Offord, DR Larson, MF Plevak, ... New England Journal of Medicine 346 (8), 564-569, 2002 | 1967 | 2002 |
Primary systemic amyloidosis: clinical and laboratory features in 474 cases RA Kyle, MA Gertz Seminars in hematology 32 (1), 45-59, 1995 | 1704 | 1995 |
Prevalence of monoclonal gammopathy of undetermined significance RA Kyle, TM Therneau, SV Rajkumar, DR Larson, MF Plevak, JR Offord, ... New England Journal of Medicine 354 (13), 1362-1369, 2006 | 1691 | 2006 |
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients SK Kumar, A Dispenzieri, MQ Lacy, MA Gertz, FK Buadi, S Pandey, ... Leukemia 28 (5), 1122-1128, 2014 | 1535 | 2014 |
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study O Landgren, RA Kyle, RM Pfeiffer, JA Katzmann, NE Caporaso, RB Hayes, ... Blood, The Journal of the American Society of Hematology 113 (22), 5412-5417, 2009 | 1431 | 2009 |
Multiple myeloma: review of 869 cases. RA Kyle Mayo Clinic Proceedings 50 (1), 29-40, 1975 | 1345 | 1975 |
POEMS syndrome: definitions and long-term outcome: Presented in abstract form at the 41st annual meeting of the American Society of Hematology, New Orleans, LA, December 3-7, 1999. A Dispenzieri, RA Kyle, MQ Lacy, SV Rajkumar, TM Therneau, DR Larson, ... Blood, The Journal of the American Society of Hematology 101 (7), 2496-2506, 2003 | 1230 | 2003 |
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 SV Rajkumar, JL Harousseau, B Durie, KC Anderson, M Dimopoulos, ... Blood, The Journal of the American Society of Hematology 117 (18), 4691-4695, 2011 | 1143 | 2011 |
Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements S Kumar, A Dispenzieri, MQ Lacy, SR Hayman, FK Buadi, C Colby, ... Journal of Clinical Oncology 30 (9), 989-995, 2012 | 1138 | 2012 |
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma RA Kyle, ED Remstein, TM Therneau, A Dispenzieri, PJ Kurtin, ... New England Journal of Medicine 356 (25), 2582-2590, 2007 | 1127 | 2007 |
Increased prevalence and mortality in undiagnosed celiac disease A Rubio–Tapia, RA Kyle, EL Kaplan, DR Johnson, W Page, F Erdtmann, ... Gastroenterology 137 (1), 88-93, 2009 | 1080 | 2009 |
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hajek, ... Leukemia 23 (2), 215-224, 2009 | 1050 | 2009 |
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis A Dispenzieri, MA Gertz, RA Kyle, MQ Lacy, MF Burritt, TM Therneau, ... Journal of clinical oncology 22 (18), 3751-3757, 2004 | 1049 | 2004 |
Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ... Leukemia 22 (2), 414-423, 2008 | 1039 | 2008 |
Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group P Sonneveld, H Avet-Loiseau, S Lonial, S Usmani, D Siegel, ... Blood, The Journal of the American Society of Hematology 127 (24), 2955-2962, 2016 | 966 | 2016 |